ArticleRMD open2021

Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study.

Marlou Thf Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.